Teva Heads Into Q2 Print With Bulls Leaning on Street Upside
TEVA enters its July 29 second-quarter earnings report having shed 7% over the past month to $30.81, with the stock down another 4% on the week. That recent softness stands in contrast to the analyst consensus, and the…